These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32462397)

  • 41. International consensus on the use of tau PET imaging agent
    Tian M; Civelek AC; Carrio I; Watanabe Y; Kang KW; Murakami K; Garibotto V; Prior JO; Barthel H; Zhou R; Hou H; Dou X; Jin C; Zuo C; Zhang H;
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):895-904. PubMed ID: 34978595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [
    Jonasson M; Wall A; Chiotis K; Leuzy A; Eriksson J; Antoni G; Nordberg A; Lubberink M
    Neuroimage Clin; 2019; 22():101681. PubMed ID: 30710871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis.
    Bocancea DI; Svenningsson AL; van Loenhoud AC; Groot C; Barkhof F; Strandberg O; Smith R; ; La Joie R; Rosen HJ; Pontecorvo MJ; Rabinovici GD; van der Flier WM; Hansson O; Ossenkoppele R
    Brain; 2023 Sep; 146(9):3719-3734. PubMed ID: 36967222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amyloid-dependent and amyloid-independent effects of Tau in individuals without dementia.
    Therriault J; Pascoal TA; Sefranek M; Mathotaarachchi S; Benedet AL; Chamoun M; Lussier FZ; Tissot C; Bellaver B; Lukasewicz PS; Zimmer ER; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P;
    Ann Clin Transl Neurol; 2021 Oct; 8(10):2083-2092. PubMed ID: 34617688
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults.
    McSweeney M; Pichet Binette A; Meyer PF; Gonneaud J; Bedetti C; Ozlen H; Labonté A; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
    Neurology; 2020 Mar; 94(11):e1190-e1200. PubMed ID: 32015176
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-invasive Standardised Uptake Value for Verification of the Use of Previously Validated Reference Region for [
    de Vries BM; Timmers T; Wolters EE; Ossenkoppele R; Verfaillie SCJ; Schuit RC; Scheltens P; van der Flier WM; Windhorst AD; van Berckel BNM; Boellaard R; Golla SSV
    Mol Imaging Biol; 2021 Aug; 23(4):550-559. PubMed ID: 33443720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of Tau Load Using [
    Golla SSV; Timmers T; Ossenkoppele R; Groot C; Verfaillie S; Scheltens P; van der Flier WM; Schwarte L; Mintun MA; Devous M; Schuit RC; Windhorst AD; Lammertsma AA; Boellaard R; van Berckel BNM; Yaqub M
    Mol Imaging Biol; 2017 Dec; 19(6):963-971. PubMed ID: 28374171
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex Differences in the Associations of Obesity with Tau, Amyloid PET, and Cognitive Outcomes in Preclinical Alzheimer's Disease: Cross-Sectional A4 Study.
    Wang X; Sundermann EE; Buckley RF; Reas ET; McEvoy LK; Banks SJ;
    J Alzheimers Dis; 2023; 95(2):615-624. PubMed ID: 37574737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Schwarz AJ; Yu P; Miller BB; Shcherbinin S; Dickson J; Navitsky M; Joshi AD; Devous MD; Mintun MS
    Brain; 2016 May; 139(Pt 5):1539-50. PubMed ID: 26936940
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [
    Risacher SL; Farlow MR; Bateman DR; Epperson F; Tallman EF; Richardson R; Murrell JR; Unverzagt FW; Apostolova LG; Bonnin JM; Ghetti B; Saykin AJ
    Acta Neuropathol Commun; 2018 Oct; 6(1):114. PubMed ID: 30373672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction effect of Alzheimer's disease pathology and education, occupation, and socioeconomic status as a proxy for cognitive reserve on cognitive performance: in vivo positron emission tomography study.
    Yasuno F; Minami H; Hattori H;
    Psychogeriatrics; 2020 Sep; 20(5):585-593. PubMed ID: 32285577
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flortaucipir F 18 Quantitation Using Parametric Estimation of Reference Signal Intensity.
    Southekal S; Devous MD; Kennedy I; Navitsky M; Lu M; Joshi AD; Pontecorvo MJ; Mintun MA
    J Nucl Med; 2018 Jun; 59(6):944-951. PubMed ID: 29191858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
    Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parametric methods for [
    Golla SS; Wolters EE; Timmers T; Ossenkoppele R; van der Weijden CW; Scheltens P; Schwarte L; Mintun MA; Devous MD; Schuit RC; Windhorst AD; Lammertsma AA; Yaqub M; van Berckel BN; Boellaard R
    J Cereb Blood Flow Metab; 2020 Feb; 40(2):365-373. PubMed ID: 30569813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging.
    Charil A; Shcherbinin S; Southekal S; Devous MD; Mintun M; Murray ME; Miller BB; Schwarz AJ
    J Alzheimers Dis; 2019; 71(3):1037-1048. PubMed ID: 31476153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ
    J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity.
    Weigand AJ; Bangen KJ; Thomas KR; Delano-Wood L; Gilbert PE; Brickman AM; Bondi MW;
    Brain Commun; 2020; 2(1):fcz046. PubMed ID: 32051933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.